| 摘要: |
| 目的:评估我院儿科中成药重复用药情况并找出经济有效的选药方法,为管理儿科中成药用药提供参考。 方法:采用改良的重 复用药评分表对我院 215 例病例进行评分,并根据评分分为 5 组。 再用无资格方案判定方法对各组病例进行评估,筛选出增量成本/ 效 果值最优的评分组。 结果:使用中成药的 215 例患儿中,婴幼儿(0~2 岁)比例最高(67. 4%)。 重复用药百分比为 12. 6%,重复用药评分 为 2 分的病例增量成本/ 效果值最小(-0. 003 5)。 结论:评分为 2 分的病例中成药单位花费成本取得的效果最好。 |
| 关键词: 中成药 重复用药 无资格方案 儿童 |
| DOI：10.13407/j.cnki.jpp.1672-108X.2023.11.007 |
|
| 基金项目: |
|
| Repetitive Medication Scoring Combined with Ineligible Prescription Determination Method in Management of Chinese Patent Medicine in Pediatrics |
| Yuan Ronghui, Fu Penggao, Duan Jun, Xu Hong, Yuan Lijialong |
| (The First People’ s Hospital of Huaihua, Hunan Huaihua 418000, China) |
| Abstract: |
| Objective: To assess the repetitive use of Chinese patent medicines in pediatrics of our hospital and identify economically effective methods of drug selection, so as to provide references for the management of Chinese patent medicines in pediatrics. Methods: Modified repetitive medication scoring table was used to score 215 patients in our hospital, and all patients were divided into five groups based on the scores. Ineligible prescription determination method was applied to evaluate each group of cases, the scoring group with the optimal incremental cost/ effectiveness ratio was screened. Results: Among the 215 pediatric patients with Chinese patent medicines, infants and young children (from 0 to 2 years) at 67. 4% took the lead. The percentage of repetitive medication was 12. 6%, and cases with repetitive medication score of 2 points had the smallest incremental cost/ effectiveness ratio (-0. 003,5). Conclusion: Cases with score of 2 points in the repetitive medication evaluation achieve the best effectiveness in terms of cost per unit of Chinese patent medicines. |
| Key words: Chinese patent medicines repetitive medication ineligible prescription children |
